Kicic Anthony, Shen Wei-Yong, Wilson Ann S, Constable Ian J, Robertson Terry, Rakoczy P Elizabeth
Stem Cell Unit, Department of Molecular Ophthalmology, Lions Eye Institute, affiliated with the Center of Ophthalmology and Visual Science, University of Western Australia, Nedlands, 6009, Western Australia, Australia.
J Neurosci. 2003 Aug 27;23(21):7742-9. doi: 10.1523/JNEUROSCI.23-21-07742.2003.
Retinal degenerations and dystrophies are the major causes of genetically inherited blindness that are characterized by the apoptotic death of the photoreceptor cell layer of the retina. To date, no treatment exists for these diseases and only recently have they been considered as candidates for gene and stem cell therapies. Here we report the ability of adult CD90+ marrow stromal cells (MSCs) to be induced by activin A, taurine, and EGF into cells (20-32%) expressing photoreceptor-specific markers rhodopsin, opsin, and recoverin in vitro. CD90+ cells were either transduced with recombinant adeno-associated virus expressing green fluorescent protein (GFP) or bromodeoxyuridine (BrdU) labeled and then injected into the subretinal space of adult Royal College of Surgeons rats. Fundus photography and angiography showed no adverse effects of CD90+ MSC transplantation. GFP-expressing cells or BrdU-positive cells covered approximately 30% of the entire retinal area. By 2 weeks after injection, CD90+ MSCs integrated into the host retina, forming structures similar to the photoreceptor layer and expressed a photoreceptor-specific marker. No teratoma formation was observed in the recipient retina. The subretinally delivered CD90+ MSCs did not stain for proliferating cell nuclear antigen, indicating that they primarily undergo differentiation rather than proliferation. In addition, we established that transplanted cells can attract synaptic vesicles and hence are potentially capable of signal transduction. This study demonstrates for the first time the partial differentiation of adult CD90+ MSCs into photoreceptors in vitro and in vivo. Our results establish a proof of concept for CD90+ MSC differentiation with autologous transplantation, which may provide a promising therapeutic strategy for the treatment of some forms of genetically inherited retinal degenerations.
视网膜变性和营养不良是遗传性失明的主要原因,其特征是视网膜光感受器细胞层发生凋亡性死亡。迄今为止,这些疾病尚无治疗方法,直到最近它们才被视为基因和干细胞疗法的候选对象。在此我们报告,成年CD90+骨髓基质细胞(MSCs)在体外可被激活素A、牛磺酸和表皮生长因子诱导分化为表达光感受器特异性标志物视紫红质、视蛋白和恢复蛋白的细胞(20%-32%)。CD90+细胞要么用表达绿色荧光蛋白(GFP)的重组腺相关病毒转导,要么用溴脱氧尿苷(BrdU)标记,然后注入成年皇家外科学院大鼠的视网膜下间隙。眼底照相和血管造影显示CD90+间充质干细胞移植没有不良反应。表达GFP的细胞或BrdU阳性细胞覆盖了整个视网膜区域的约30%。注射后2周,CD90+间充质干细胞整合到宿主视网膜中,形成类似于光感受器层的结构,并表达光感受器特异性标志物。在受体视网膜中未观察到畸胎瘤形成。视网膜下注射的CD90+间充质干细胞未对增殖细胞核抗原染色,表明它们主要进行分化而非增殖。此外,我们证实移植的细胞可以吸引突触小泡,因此具有信号转导的潜力。本研究首次证明成年CD90+间充质干细胞在体外和体内可部分分化为光感受器。我们的结果为自体移植的CD90+间充质干细胞分化建立了概念验证,这可能为治疗某些形式的遗传性视网膜变性提供一种有前景的治疗策略。